📰 Abt News
Page 33 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
January 31, 2024
Marco Investment Management LLC decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,138 shares of the healthcare product maker’s stock after selling 2,095 shares during the quarter. Marco Investment Management […]
January 31, 2024
Arcblock (ABT) traded up 11.1% against the U.S. dollar during the 24-hour period ending at 16:00 PM E.T. on January 31st. Arcblock has a market cap of $39.65 million and approximately $9.41 million worth of Arcblock was traded on exchanges in the last day. In the last seven days, Arcblock has traded up 80.7% against […]
January 31, 2024
Great Lakes Advisors LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 28.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,316,125 shares of the healthcare product maker’s stock after acquiring an additional 292,882 shares during the quarter. Abbott Laboratories accounts for approximately 1.2% of Great Lakes Advisors […]
January 31, 2024
Chartwell Investment Partners LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% during the third quarter, Holdings Channel.com reports. The fund owned 138,701 shares of the healthcare product maker’s stock after buying an additional 844 shares during the period. Chartwell Investment Partners LLC’s holdings in Abbott Laboratories were worth $13,433,000 at […]
January 30, 2024
Impax Asset Management Group plc grew its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 65.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 793,076 shares of the healthcare product maker’s stock after purchasing an additional 314,819 shares […]
January 30, 2024
CORDA Investment Management LLC. raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,386 shares of the healthcare product maker’s stock after acquiring an additional 186 shares during the […]
January 30, 2024
M. Kulyk & Associates LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,860 shares of the healthcare product maker’s stock after selling 344 shares during the period. M. Kulyk & […]
January 30, 2024
M. Kulyk & Associates LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,860 shares of the healthcare product maker’s stock after selling 344 shares […]
January 29, 2024
Hudock Inc. grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,306 shares of the healthcare product maker’s stock after purchasing an additional 316 shares during the period. Hudock Inc.’s holdings in […]
January 29, 2024
Cassaday & Co Wealth Management LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 35,055 shares of the healthcare product maker’s stock after purchasing an additional 649 shares during the […]